Drug Landscape ›
Epidural Morphine ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 10
Most-reported reactions
Anorexia — 1 report (10%) Asthenia — 1 report (10%) Disorientation — 1 report (10%) Feeling Hot — 1 report (10%) Hot Flush — 1 report (10%) Insomnia — 1 report (10%) Muscle Spasms — 1 report (10%) Musculoskeletal Stiffness — 1 report (10%) Nausea — 1 report (10%) Pain — 1 report (10%)
Source database →
Epidural Morphine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Epidural Morphine approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Epidural Morphine in United States?
Columbia University is the originator. The local marketing authorisation holder may differ — check the official source linked above.